Pacific Biosciences of California, Inc., or PacBio annouced the launch of their Revio Sequencing system on 26th of October, 2022.

This long read sequencing technology is designed to effectively sequence up to 1300 human whole genomes at 30X coverage while lowering its costs.

This system is thought to increase throughput and is applicable for the analysis of cancer and rare diseases along with agri-genomics.

As the first Indian Company to adopt this revolutionary technology, Bencos will be offering unique services at an affordable range contributing to the treatment of rare diseases which are often difficult to diagnosis.